CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study 期刊论文
2019, 卷号: 10, 期号: 7, 页码: 1521-1532
作者:  Liang Hongge;  Song Xia;  Zhang Yuhui;  Zhang Shucai;  Li Fang
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study) 期刊论文
2018, 卷号: 9, 期号: 12, 页码: 1795-1800
作者:  Xu, Yan;  Zhang, Li;  Fang, Jian;  Wang, Ziping;  Li, Junling
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study 期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1461-1469
作者:  Cheng, Ying;  Wang, Yan;  Zhao, Jun;  Liu, Yunpeng;  Gao, Hongjun
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文
2017, 卷号: 13, 期号: 1, 页码: 87-103
作者:  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 期刊论文
2017, 卷号: 35
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI. 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE). 期刊论文
2016, 卷号: 34, 期号: 15
作者:  Shi, Yuankai;  Wang, Lin;  Han, Baohui;  Li, Wei;  Yu, Ping
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
A retrospective analysis of the ICOGEN clinical trial demonstrates the utility of VeriStrat to predict outcome in an all Chinese cohort treated with EGFR TKI. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Shi, Yuankai;  Wang, Lin;  Han, Baohui;  Li, Wei;  Yu, Ping
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace